These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12377655)

  • 21. 2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia.
    Robak T; Błasińska-Morawiec M; Krykowski E; Hansz J; Komarnicki M; Kazimierczak M; Konopka L; Maj S; Hellmann A; Zaucha JM; Urasiński L; Zdziarska B; Kotlarek-Haus S; Usnarska-Zubkiewicz L; Kuratowska Z; Dwilewicz-Trojaczek J; Hołowiecki J; Krawczyk-Kulis M; Grieb P
    Leuk Lymphoma; 1996 Jun; 22(1-2):107-11. PubMed ID: 8724536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO
    Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
    Zinzani PL; Tani M; Marchi E; Stefoni V; Alinari L; Musuraca G; Gabriele A; Pileri S; Baccarani M
    Haematologica; 2004 Mar; 89(3):309-13. PubMed ID: 15020269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).
    Betticher DC; Ratschiller D; Hsu Schmitz SF; von Rohr A; Hess U; Zulian G; Wernli M; Tichelli A; Tobler A; Fey MF; Cerny T
    Ann Oncol; 1998 Jul; 9(7):721-6. PubMed ID: 9739437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia.
    Saven A; Burian C; Adusumalli J; Koziol JA
    Blood; 1999 Apr; 93(8):2471-7. PubMed ID: 10194424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G; Liliemark J
    Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia.
    Damasio EE; Resegotti L; Masoudi B; Bruni R; Cerri R; Isaza A; Clavio M; Risso M; Rossi E; Spriano M; Truini M
    Recenti Prog Med; 1998 Feb; 89(2):68-73. PubMed ID: 9558908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
    Goodman GR; Burian C; Koziol JA; Saven A
    J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hairy cell leukemia therapy by cladribine].
    Ogura M
    Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).
    Zenhäusern R; Schmitz SF; Solenthaler M; Heim D; Meyer-Monard S; Hess U; Leoncini L; Bargetzi M; Rufener B; Tobler A
    Leuk Lymphoma; 2009 Sep; 50(9):1501-11. PubMed ID: 19672771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment.
    Raspadori D; Rondelli D; Birtolo S; Lenoci M; Nardi G; Scalia G; Sestigiani C; Tozzi M; Marotta G; Lauria F
    Leukemia; 1999 Aug; 13(8):1254-7. PubMed ID: 10450754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
    Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
    Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia.
    Piro LD; Ellison DJ; Saven A
    Leuk Lymphoma; 1994; 14 Suppl 1():121-5. PubMed ID: 7820043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retreatment with 2-CdA of progressed HCL patients.
    Lauria F; Benfenati D; Raspadori D; Rondelli D; Ventura MA; Pileri S; Sabattini E; Poggi S; Benni M; Tura S
    Leuk Lymphoma; 1994; 14 Suppl 1():143-5. PubMed ID: 7820047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.
    Tallman MS; Hakimian D; Rademaker AW; Zanzig C; Wollins E; Rose E; Peterson LC
    Blood; 1996 Sep; 88(6):1954-9. PubMed ID: 8822913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.